Results 121 to 130 of about 28,036 (235)
Platelets and megakaryocytes in cancer
Platelets have important roles in hemostasis but also actively participate in cancer metastasis and inflammatory processes. They are produced by large precursor cells, the megakaryocytes, residing mainly in the bone marrow. Clinically, elevated platelet counts and/or increased platelet-to-lymphocyte ratio are being explored as biomarkers of metastatic ...
openaire +2 more sources
ABSTRACT Extracellular vesicles (EVs) mediate intercellular communication within the tumour microenvironment by carrying cargoes from paracrine parent cells. EVs have attracted great research interest for their ability to carry nucleic acids into recipient cells and modulate cellular functions.
Gaoge Sun +11 more
wiley +1 more source
Aberrant polyploidization pathways in megakaryocytes as therapeutic targets in leukemia. [PDF]
Obeagu EI.
europepmc +1 more source
Under shear flow, stretched vWF captures platelets and EVs, and TF‐positive EVs amplify platelet activation and aggregation. Although tumour cells do not bind vWF directly, the resulting microthrombi trap circulating tumour cells and promote metastatic progression.
Yuanyuan Wang +16 more
wiley +1 more source
Dysplastic Megakaryocytes in a Gallbladder Neck Lymph Node in a Patient With Essential Thrombocythemia: A Case Report. [PDF]
Balcı M.
europepmc +1 more source
ABSTRACT Pancytopenia accompanied by chimeric antigen receptor T cell (CAR‐T) therapy is termed immune effector cell‐associated hematopoietic toxicity (ICAHT), which is often sustained and refractory to supportive care. We report a case of a 52‐year‐old man with multiple myeloma who developed severe ICAHT with secondary myelofibrosis (sMF) after ...
Keishi Ogura +9 more
wiley +1 more source
Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming. [PDF]
Carminita E +17 more
europepmc +1 more source
Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB‐9778
ABSTRACT CD148 is the primary receptor‐type protein tyrosine phosphatase (PTP) regulating platelet activation, and its inhibition has been proposed as a novel anti‐thrombotic strategy with potentially lower bleeding risk than current therapies. However, selective and potent inhibitors of CD148 are currently lacking.
Lina El Badaoui +3 more
wiley +1 more source
Cyclopropene fatty acids have been made that allow the study of fatty acid uptake in complex mixtures of immune cells with single cell resolution and combined with metabolic and proteomic analysis so that for the first time nutrient uptake can be correlated to the phenotype of single immune cell.
Luuk Reinalda +14 more
wiley +2 more sources
Assessing bleeding risk by thromboelastography when automated platelet count fails due to giant platelets. [PDF]
Ye Z +7 more
europepmc +1 more source

